Skip to main content

New OC National FLS Implementation Lead

Headshot of Dr. Sonia SinghOsteoporosis Canada is pleased to announce that effective November 1, 2023 Dr. Sonia Singh will be joining the organization as the new OC National FLS Implementation Lead, previously known as the FLS Chief Scientific Officer.

Dr. Singh is a hospitalist physician and osteoporosis consultant based at Peace Arch Hospital (PAH) in White Rock, as well as the medical lead for British Columbia’s first FLS and Fraser Health’s Healthy Bones Clinic at PAH.

She worked for 25 years as an Emergency Room physician and frequently cared for patients presenting with repeated fractures related to osteoporosis. Dr. Singh has been a champion for FLS (Fracture Liaison Service) since 2012.

Dr. Singh has been successful with a number of research grant awards in the area of osteoporosis and fall prevention, including an Implementation Science Team grant from Michael Smith Health Research BC for “Breaking the cycle of recurrent fracture: Scaling up a secondary fracture prevention program in Fraser Health to inform spread across British Columbia”. She is the Peace Arch Hospital Foundation Health Research Champion and holds academic appointments as Clinical Assistant Professor, Faculty of Medicine, UBC and Adjunct Professor, Faculty of Health Sciences, SFU.

In addition, she is a member of the Scientific Advisory Committee of Osteoporosis Canada, the co-chair of the Fragility Fracture Network Special Interest Group in Secondary Fracture Prevention, and the co-chair of the BC Coalition of Osteoporosis Physicians FLS Special Interest Group.

In 2015, Dr. Singh was awarded a Fraser Health Above and Beyond Award for Evidence Based Practice and in 2022 was presented with the Osteoporosis Canada’s Community Backbone Award.


OC MAKES THE NEWS – RECENT ITEMS

2024 Gideon A. Rodan Excellence in Mentorship Award

August 16, 2024
Latest News 2024 Gideon A. Rodan Excellence in Mentorship Award Angela Cheung, M.D., Ph.D. is the recipient of the 2024 Gideon A. Rodan Excellence in Mentorship Award which is given […]

Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis.

May 31, 2024
Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement

April 19, 2024
Latest News Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement April  19, 2024 The International Society for Clinical Densitometry (ISCD) is the leading membership organization for professionals working to assess, […]
© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001